Cargando…

A novel genotype of MVA that efficiently replicates in single cell suspensions

Detalles Bibliográficos
Autores principales:	Jordan, Ingo, Sandig, Volker
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981672/ http://dx.doi.org/10.1186/1753-6561-7-S6-O1

Ejemplares similares

A Genotype of Modified Vaccinia Ankara (MVA) that Facilitates Replication in Suspension Cultures in Chemically Defined Medium
por: Jordan, Ingo, et al.
Publicado: (2013)

Purification of modified vaccinia virus Ankara from suspension cell culture
por: Jordan, Ingo, et al.
Publicado: (2015)

High-cell-density cultivations to increase MVA virus production
por: Vázquez-Ramírez, Daniel, et al.
Publicado: (2018)

Evidence for Env-V2 sieve effect in breakthrough SIV (MAC251) infections in rhesus monkeys vaccinated with Ad26/MVA and MVA/Ad26 constructs
por: Sina, S, et al.
Publicado: (2012)

A novel Plasmodium vivax vaccine based on recombinant chimpanzee adenovirus ChAd63 and MVA expressing TRAP
por: Bauza, Karolis, et al.
Publicado: (2012)

High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system
por: Vázquez-Ramírez, Daniel, et al.
Publicado: (2019)

Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1.CR.pIX
por: Trabelsi, Khaled, et al.
Publicado: (2022)

A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA)
por: Jordan, Ingo, et al.
Publicado: (2019)

Vaccination with MVA/HIV induces differential recruitment of monocyte subsets into the circulation and monocyte-specific transcriptional programs
por: Andersen-Nissen, E, et al.
Publicado: (2012)

Significant protection from infection and AIDS progression after gastrointestinal and oral vaccinations, respectively, with a SIV DNA/rMVA vaccine
por: Aldovini, A, et al.
Publicado: (2012)

Highly efficient, chemically defined and fully scalable biphasic production of vaccine viruses
por: Jordan, Ingo, et al.
Publicado: (2011)

OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial
por: Currier, JR, et al.
Publicado: (2009)

P19-19. MVA vaccines are efficiently cross-presented by DCs and do not enhance HIV replication in DC/T cell cultures
por: Brandler, S, et al.
Publicado: (2009)

Potent cellular and humoral immunity against HIV-1 elicited in mice by a DNA-prime/MVA-boost vaccine regimen intended for human use
por: Wahren, Britta, et al.
Publicado: (2006)

Human pluripotent stem cell process parameter optimization in a small scale suspension bioreactor
por: Lipsitz, Yonatan Y, et al.
Publicado: (2015)

Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults
por: Joachim, A, et al.
Publicado: (2012)

Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
por: Ondondo, Beatrice, et al.
Publicado: (2006)

OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge
por: Kannanganat, S, et al.
Publicado: (2009)

Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells
por: Lohr, Verena, et al.
Publicado: (2012)

Antigen-specific T lymphocyte responses elicited by a DNA – MVA HIV CN54gp140 immunization regime are significantly altered by the TLR4 adjuvant GLA
por: McKay, PF, et al.
Publicado: (2012)

Potent suppression of HIV viral replication by a novel inhibitor of Tat
por: Mousseau, Guillaume, et al.
Publicado: (2012)

Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures
por: Göbel, Sven, et al.
Publicado: (2022)

OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees
por: Nilsson, C, et al.
Publicado: (2009)

OP4-5 Genetic variants of human parvovirus B19 in South Africa: co-circulation of three genotypes and identification of a novel subtype of genotype 1.
por: Corcoran, C., et al.
Publicado: (2009)

S8.5c MLST genotyping and phylogenetics of AD-hybrids
por: Cogliati, Massimo, et al.
Publicado: (2022)

Effect of respiratory suspension on the computation of volume-based early peak filling rate to late peak filling rate ratio
por: Pednekar, Amol, et al.
Publicado: (2016)

Expression profiling of breast cancer, influence of tumor genotype and patient genotype
por: Borresen-Dale, A-L
Publicado: (2003)

Partial inhibition of HIV replication by type-I interferons: impact of cell-to-cell viral transfer
por: Vendrame, Daniela, et al.
Publicado: (2009)

A single dose of SAAVI MVA-C reboosts rhesus macaques after more than 3 years post DNA-MVA prime-boost vaccination
por: Chege, GK, et al.
Publicado: (2012)

BEAT(® )the bispecific challenge: a novel and efficient platform for the expression of bispecific IgGs
por: Moretti, Pierre, et al.
Publicado: (2013)

Using the lagging strand to study chromosome replication
por: McGuffee, S, et al.
Publicado: (2013)

Immune activation, viral replication and mucosal depletion
por: Grossman, Zvi
Publicado: (2006)

HIV-1 integrase SUMOylation and viral replication
por: Zamborlini, Alessia, et al.
Publicado: (2011)

Occult replication of a conditionally-live attenuated SIV profoundly upregulates T effector memory cell frequency
por: Manoussaka, Maria, et al.
Publicado: (2011)

Calibration and accuracy of the geno2pheno co-receptor algorithm for predicting HIV tropism for single and triplicate measurements of V3 genotype
por: Swenson, LC, et al.
Publicado: (2010)

Genotype-phenotype: correlations and emerging spectrum
por: Reuser, Arnold
Publicado: (2013)

Exploiting replication deficiencies to illuminate HIV: host interactions
por: Malim, Michael
Publicado: (2011)

Interplay between HIV-1 replication and RNAi effectors
por: Chable-Bessia, Christine, et al.
Publicado: (2009)

O20 - Human rhinovirus replication-dependent induction of micro-RNAs in human bronchial epithelial cells
por: Megremis, Spyridon, et al.
Publicado: (2014)

Matrix and Backstage: Cellular Substrates for Viral Vaccines
por: Jordan, Ingo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_alcv191h906b9kt3ntpq9goqa6